Global Graft-Versus-Host Disease GVHD Treatment Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,800	472 Pages	Data Bridge Market Research	April, 2024	DAABD18813138

Best Price Guarantee
Price	from $4,800
Length	472 Pages
Publisher	Data Bridge Market Research
Published Date	April, 2024
SKU	DAABD18813138

Global Graft-Versus-Host Disease GVHD Treatment Market

Global Graft-Versus-Host Disease (GVHD) treatment market is expected to reach USD 5,496,482.42 thousand by 2031, from USD 3,940,000.00 thousand in 2023 growing at the CAGR of 4.4% in the forecast period of 2024 to 2031.
Market Segmentation:
Global Graft-Versus-Host Disease (GVHD) Treatment Market, By Treatment (Medication and Therapy), Type (Chronic GVHD, Acute GVHD, and Prophylactic), Gender (Female and Male), Age (Adults and Pediatric), Method of Administration (Oral, Intravenous, Topical, and Others), End User (Hospitals, Transplant Centers, Institutes and Specialty Centers), Distribution Channel (Direct Tender, Retail Sales and Others), By Country (U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Belgium, Russia, Switzerland, Denmark, Rest of Europe, China, Japan, Australia, South Korea, India, Malaysia, Singapore, Philippines, Indonesia, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Kuwait, Bahrain, and Rest of Middle East and Africa)– Industry Trends and Forecast to 2031
Overview of Global Graft-Versus-Host Disease (GVHD) Treatment Market Dynamics:

Drivers
• Increasing incidence of hematopoietic stem cell transplants (HSCT)
• Awareness campaigns and patient education
• Advancements in treatment options

Restraints
• High cost of medications and supportive care
• Disease heterogeneity

Opportunities
• Market expansion through strategic initiatives and partnership
• Growing pipeline of innovative drugs for GVHD treatment
• Empowering patient centric approach to GVHD treatment
Challenges
• Stringent regulations in GVHD therapies
• Safety concerns and complexities during treatment

Market Players

The key market players for global Graft-Versus-Host Disease (GVHD) treatment market are listed below:

• Bristol-Myers Squibb Company
• AbbVie Inc
• Novartis AG
• Janssen Global Services, LLC
• Mallinckrodt
• Incyte
• Sanofi
• Alkem Laboratories Ltd
• Astellas Pharma Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Global Graft-versus-host Disease (Gvhd) Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 DBMR Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 DBMR Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis_; 4.2 Porter's Five Forces Model
5 Pipe Line Analysis Of Graft Versus Host Disease Market
6 Regulation
7 Market Overview: 7.1 Drivers; 7.1.1 Increasing Incidence Of Hematopoietic Stem Cell Transplants (Hsct); 7.1.2 Awareness Campaigns And Patient Education; 7.1.3 Advancements In Treatment Options; 7.2 Restraints; 7.2.1 High Cost Of Medications And Supportive Care; 7.2.2 Disease Heterogeneity; 7.3 Opportunities; 7.3.1 Market Expansion Through Strategic Initiatives And Partnership; 7.3.2 Growing Pipeline Of Innovative Drugs For Gvhd Treatment; 7.3.3 Empowering Patient-centric Approach To Gvhd Treatment; 7.4 Challenges; 7.4.1 Stringent Regulations In Gvhd Therapies; 7.4.2 Safety Concern And Complexities During Treatment
8 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Type: 8.1 Overview; 8.2 Chronic Gvhd; 8.2.1 Corticosteroids; 8.2.1.1 Prednisolone; 8.2.1.2 Methylprednisolone; 8.2.2 Immunosuppressive; 8.2.2.1 Mycophenolate Mofetil (Mmf); 8.2.2.2 Methotrexate (Mtx); 8.2.2.3 Ibrutinib; 8.2.2.4 Belumosudil; 8.2.2.5 Ruxolitinib; 8.2.2.6 Antithymocyte Globulin (Atg); 8.2.2.7 Others; 8.2.3 Calcineurin Inhibitors; 8.2.4 Others; 8.2.4.1 Branded; 8.2.4.1.1 Rezurock; 8.2.4.1.2 Imbruvica; 8.2.4.1.3 Jakafi; 8.2.4.2 Generic; 8.3 Acute Gvhd; 8.3.1 Corticosteroids; 8.3.1.1 Methylprednisolone; 8.3.1.2 Prednisolone; 8.3.2 Immunosuppressive; 8.3.2.1 Mycophenolate Mofetil (Mmf); 8.3.2.2 Ruxolitinib; 8.3.2.3 Others; 8.3.3 Calcineurin Inhibitors; 8.3.3.1 Tacrolimus (Tac); 8.3.3.2 Cyclosporin (Csa); 8.3.4 Others; 8.4 Prophylactic; 8.4.1 Cyclosporin (Csa); 8.4.2 Methotrexate (Mtx); 8.4.3 Tacrolimus (Tac); 8.4.4 Methylprednisolone; 8.4.5 Others; 8.4.5.1 Generic; 8.4.5.2 Branded; 8.4.5.2.1 Orencia; 8.4.5.2.2 Others
9 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration: 9.1 Overview; 9.2 Oral; 9.3 Intravenous; 9.4 Topical; 9.5 Others
10 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment: 10.1 Overview; 10.2 Medication; 10.2.1 Corticosteroids; 10.2.1.1 Methylprednisolone; 10.2.1.2 Prednisolone; 10.2.2 Immunosuppressive; 10.2.2.1 Mycophenolate Mofetil (Mmf); 10.2.2.2 Methotrexate (Mtx); 10.2.2.3 Ibrutinib; 10.2.2.4 Belumosudil; 10.2.2.5 Ruxolitinib; 10.2.2.6 Antithymocyte Globulin (Atg); 10.2.2.7 Others; 10.2.3 Calcineurin Inhibitors; 10.2.3.1 Tacrolimus (Tac); 10.2.3.2 Cyclosporin (Csa); 10.2.3.3 Others; 10.2.4 Branded; 10.2.4.1 Rezurock; 10.2.4.2 Imbruvica; 10.2.4.3 Jakafi; 10.2.4.4 Orencia; 10.2.4.5 Others; 10.2.5 Generic; 10.3 Therapy
11 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Age: 11.1 Overview; 11.2 Adults; 11.3 Pediatric
12 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Gender: 12.1 Overview; 12.2 Female; 12.3 Male
13 Global Graft-versus-host Disease (Gvhd) Treatment Market, By End User: 13.1 Overview; 13.2 Hospitals; 13.2.1 Public; 13.2.2 Private; 13.3 Transplant Centers; 13.4 Institutes; 13.5 Speciality Centers
14 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel: 14.1 Overview; 14.2 Direct Tender; 14.3 Retail Sales; 14.3.1 Hospital Pharmacy; 14.3.2 Retail Pharmacy; 14.3.3 Online Pharmacy; 14.4 Others
15 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Region: 15.1 Overview; 15.2 North America; 15.2.1 U.S; 15.2.2 Canada; 15.2.3 Mexico; 15.3 Europe; 15.3.1 Germany; 15.3.2 France; 15.3.3 Italy; 15.3.4 U.K.; 15.3.5 Spain; 15.3.6 Belgium; 15.3.7 Russia; 15.3.8 Switzerland; 15.3.9 Denmark; 15.3.10 Rest Of Europe; 15.4 Asia-pacific; 15.4.1 Japan; 15.4.2 China; 15.4.3 Australia; 15.4.4 South Korea; 15.4.5 India; 15.4.6 Malaysia; 15.4.7 Singapore; 15.4.8 Philippines; 15.4.9 Indonesia; 15.4.10 Rest Of Asia Pacific; 15.5 Middle East And Africa; 15.5.1 South Africa; 15.5.2 Saudi Arabia; 15.5.3 U.A.E.; 15.5.4 Kuwait; 15.5.5 Bahrain; 15.5.6 Rest Of Middle East And Africa; 15.6 South America; 15.6.1 Brazil; 15.6.2 Argentina; 15.6.3 Rest Of South America
16 Global Graft Versus Host Disease (Gvhd) Treatment Market: Company Landscape: 16.1 Company Share Analysis: Global; 16.2 Company Share Analysis: North America; 16.3 Company Share Analysis: Europe; 16.4 Company Share Analysis: Asia-pacific
17 Swot Analysis
18 Company Profiles: 18.1 Bristol-myers Squibb Company; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Developments; 18.2 Abbvie Inc.; 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Share Analysis; 18.2.4 Product Portfolio; 18.2.5 Recent Developments; 18.3 Novartis Ag; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Company Share Analysis; 18.3.4 Product Portfolio; 18.3.5 Recent Developments; 18.4 Janssen Global Services, Llc; 18.4.1 Company Snapshot; 18.4.2 Revenue Analysis; 18.4.3 Company Share Analysis; 18.4.4 Product Portfolio; 18.4.5 Recent Developments; 18.5 Mallinckrodt; 18.5.1 Company Snapshot; 18.5.2 Revenue Analysis; 18.5.3 Company Share Analysis; 18.5.4 Product Portfolio; 18.5.5 Recent Developments; 18.6 Alkem Laboratories Ltd.; 18.6.1 Company Snapshot; 18.6.2 Revenue Analysis; 18.6.3 Product Portfolio; 18.6.4 Recent Development; 18.7 Astellas Pharma Inc.; 18.7.1 Company Snapshot; 18.7.2 Revenue Analysis; 18.7.3 Product Portfolio; 18.7.4 Recent Development; 18.8 Incyte.; 18.8.1 Company Snapshot; 18.8.2 Revenue Analysis; 18.8.3 Product Portfolio; 18.8.4 Recent Developments; 18.9 Sanofi; 18.9.1 Company Snapshot; 18.9.2 Revenue Analysis; 18.9.3 Product Portfolio; 18.9.4 Recent Developments
19 Questionnaire
20 Related Reports: Table 1 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 2 Global Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 3 Global Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 4 Global Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 5 Global Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 6 Global Chronic Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 7 Global Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 8 Global Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 9 Global Acute Gvhd In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 10 Global Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 11 Global Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 12 Global Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 13 Global Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 14 Global Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 15 Global Prophylactic In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 16 Global Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Type, 2022-2031 (Usd Thousand); Table 17 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Method Of Administration, 2022-2031 (Usd Thousand); Table 18 Global Oral In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 19 Global Intravenous In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 20 Global Topical In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 21 Global Others In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 22 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Treatment, 2022-2031 (Usd Thousand); Table 23 Global Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 24 Global Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 25 Global Corticosteroids In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 26 Global Immunosuppressive In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 27 Global Calcineurin Inhibitors In Graft-versus-host Disease (Gvhd) Treatment Market, By Drugs, 2022-2031 (Usd Thousand); Table 28 Global Medication In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 29 Global Branded In Graft-versus-host Disease (Gvhd) Treatment Market, By Drug Type, 2022-2031 (Usd Thousand); Table 30 Global Therapy In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 31 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Age, 2022-2031 (Usd Thousand); Table 32 Global Adults In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 33 Global Pediatric In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 34 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Gender, 2022-2031 (Usd Thousand); Table 35 Global Female In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 36 Global Male In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 37 Global Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 38 Lobal Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 39 Global Hospitals In Graft-versus-host Disease (Gvhd) Treatment Market, By End User, 2022-2031 (Usd Thousand); Table 40 Global Transplant Centers In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 41 Global Institutes In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 42 Global Speciality Centers In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 43 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 44 Global Direct Tender In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 45 Global Retail Sales In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 46 Global Retail Sales In Graft-versus-host Disease (Gvhd) Treatment Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 47 Global Others In Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Table 48 Global Graft-versus-host Disease (Gvhd) Treatment Market, By Region, 2022-2031 (Usd Thousand); Figure 1 Global Graft-versus-host Disease (Gvhd) Treatment Market: Segmentation; Figure 2 Global Graft-versus-host Disease (Gvhd) Treatment Market: Data Triangulation; Figure 3 Global Graft-versus-host Disease (Gvhd) Treatment Market: Droc Analysis; Figure 4 Global Graft-versus-host Disease (Gvhd) Treatment Market: Global Vs Regional Market Analysis; Figure 5 Global Graft-versus-host Disease (Gvhd) Treatment Market: Company Research Analysis; Figure 6 Global Graft-versus-host Disease (Gvhd) Treatment Market: Interview Demographics; Figure 7 Global Graft-versus-host Disease (Gvhd) Treatment Market: Market Application Coverage Grid; Figure 8 Global Graft-versus-host Disease (Gvhd) Treatment Market: DBMR Market Position Grid; Figure 9 Global Graft-versus-host Disease (Gvhd) Treatment Market: Vendor Share Analysis; Figure 10 Global Graft-versus-host Disease (Gvhd) Treatment Market: Segmentation; Figure 11 The Growing Number Of Stem Cell Transplantations Is Driving The Growth Of The Global Graft-versus-host Disease (Gvhd) Treatment Market From 2024 To 2031; Figure 12 The Treatment Segment Is Expected To Account For The Largest Share Of The Global Graft-versus-host Disease (Gvhd) Treatment Market In 2024 And 2031; Figure 13 North America Is Expected To Dominate The Global Graft-versus-host Disease (Gvhd) Treatment Market And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period Of 2024 To 2031; Figure 14 North America Is The Fastest-growing Region For Graft-versus-host Disease (Gvhd) Treatment Market In The Forecast Period Of 2024 To 2031; Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Global Graft-versus-host Disease (Gvhd) Treatment Market; Figure 16 Global Graft-versus-host Disease (Gvhd) Treatment Market: By Type 2023; Figure 17 Global Graft-versus-host Disease (Gvhd) Treatment Market: By Type, 2024-2031 (Usd Thousand); Figure 18 Global Graft-versus-host Disease (Gvhd) Treatment Market: By Type, Cagr (2024-2031); Figure 19 Global Graft-versus-host Disease (Gvhd) Treatment Market By Type, Lifeline Curve; Figure 20 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Method Of Administration, 2023; Figure 21 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Method Of Administration, 2024-2031 (Usd Thousand); Figure 22 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Method Of Administration, Cagr (2024-2031); Figure 23 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Method Of Administration, Lifeline Curve; Figure 24 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, 2023; Figure 25 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, 2024-2031 (Usd Thousand); Figure 26 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, Cagr (2024-2031); Figure 27 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Treatment, Lifeline Curve; Figure 28 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Age, 2023; Figure 29 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Age, 2024-2031 (Usd Thousand); Figure 30 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Age, Cagr (2024-2031); Figure 31 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Age, Lifeline Curve; Figure 32 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Gender, 2023; Figure 33 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Gender, 2024-2031 (Usd Thousand); Figure 34 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Gender, Cagr (2024-2031); Figure 35 Global Graft-versus-host Disease (Gvhd) Treatment Market : By Gender, Lifeline Curve; Figure 36 Global Graft-versus-host Disease (Gvhd) Treatment Market: By End User 2023; Figure 37 Global Graft-versus-host Disease (Gvhd) Treatment Market: By End User, 2024-2031 (Usd Thousand); Figure 38 Global Graft-versus-host Disease (Gvhd) Treatment Market: End User, Cagr (2024-2031); Figure 39 Global Graft-versus-host Disease (Gvhd) Treatment Market End User, Lifeline Curve; Figure 40 Global Graft-versus-host Disease (Gvhd) Treatment Market: By Distribution Channel 2023; Figure 41 Global Graft-versus-host Disease (Gvhd) Treatment Market: By Distribution Channel, 2024-2031 (Usd Thousand); Figure 42 Global Graft-versus-host Disease (Gvhd) Treatment Market: Distribution Channel, Cagr (2024-2031); Figure 43 Global Graft-versus-host Disease (Gvhd) Treatment Market Distribution Channel, Lifeline Curve; Figure 44 Global Graft-versus-host Disease (Gvhd) Treatment Market: Snapshot (2023); Figure 45 Global Graft Versus Host Disease (Gvhd) Treatment Market: Company Share 2023 (%); Figure 46 North America Graft Versus Host Disease (Gvhd) Treatment Market: Company Share 2023 (%); Figure 47 Europe Graft Versus Host Disease (Gvhd) Treatment Market: Company Share 2023 (%); Figure 48 Aisa-pacific Graft Versus Host Disease (Gvhd) Treatment Market: Company Share 2023 (%)